Show simple item record

Authordc.contributor.authorRubio Cabezas, Oscar 
Authordc.contributor.authorGómez, José Luis 
Authordc.contributor.authorGleisner, Andrea 
Authordc.contributor.authorHattersley, Andrew T. 
Authordc.contributor.authorCodner Dujovne, Ethel 
Admission datedc.date.accessioned2018-03-19T19:41:29Z
Available datedc.date.available2018-03-19T19:41:29Z
Publication datedc.date.issued2016-10
Cita de ítemdc.identifier.citationJ Clin Endocrinol Metab, October 2016, 101(10):3555–3558es_ES
Identifierdc.identifier.other10.1210/jc.2016-2319
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/146901
Abstractdc.description.abstractContext: Biallelic mutations in NEUROG3 are known to cause early-onset malabsorptive diarrhea due to congenital anendocrinosis and diabetes mellitus at a variable age. No other endocrine disorders have been described so far. We report four patients with homozygous NEUROG3 mutations who presented with short stature and failed to show any signs of pubertal development. Case Description: Four patients (two males, two females) were diagnosed with homozygous mutations in NEUROG3 on the basis of congenital malabsorptive diarrhea and diabetes. All four had severe short stature and failed to develop secondary sexual characteristics at an appropriate age, despite some having normal body mass index. The absence of gonadal function persisted into the third decade in one patient. Upon testing, both basal and stimulated LH and FSH levels were low, with the remaining pituitary hormones within the normal range. Magnetic resonance imaging scans of the hypothalamicpituitary axis did not reveal structural abnormalities. A diagnosis of hypogonadotropic hypogonadism was made, and replacement therapy with sex hormones was started. Conclusions: The high reproducibility of this novel phenotype suggests that central hypogonadism and short stature are common findings in patients with mutations in NEUROG3. Growth rate needs to be carefully monitored in these patients, who also should be routinely screened for hypogonadism when they reach the appropriate age. NEUROG3 mutations expand on the growing number of genetic causes of acquired hypogonadotropic hypogonadism.es_ES
Patrocinadordc.description.sponsorshipInstituto de Salud Carlos III, Spain CP11/00263 European Community's Seventh Framework Programme 223211 BOLD (EU FP7-PEOPLE-ITN Biology of Liver and Pancreatic Development and Disease) Diabetes UK Wellcome Trust Senior Investigator Award "Juan Rodes" Clinical Research Fellowship from the Instituto de Salud Carlos III, Spain JR13/00018 National Institute for Health Researches_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherEndocrine Soces_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceJournal of Clinical Endocrinology & Metabolismes_ES
Títulodc.titleHypogonadotropic hypogonadism and short stature in patients with diabetes due to Neurogenin 3 deficiencyes_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorpgves_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile